Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy

You have accessJournal of UrologyPodium, Tuesday, May 24, 2005, 1:00 - 3:00pm1 Apr 20051319: Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Nedaplatin in Patients with Urothelial Cancer who Have Received Prior Cisplatin-Based Therapy Nobuo Shinohara, Shin Suzuki, Takashige Abe, Ataru Sazawa, Toru Harabayashi, and Katsuya Nonomura Nobuo ShinoharaNobuo Shinohara More articles by this author , Shin SuzukiShin Suzuki More articles by this author , Takashige AbeTakashige Abe More articles by this author , Ataru SazawaAtaru Sazawa More articles by this author , Toru HarabayashiToru Harabayashi More articles by this author , and Katsuya NonomuraKatsuya Nonomura More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)35464-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "1319: Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Nedaplatin in Patients with Urothelial Cancer who Have Received Prior Cisplatin-Based Therapy." The Journal of Urology, 173(4S), p. 358 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 173Issue 4SApril 2005Page: 358 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Nobuo Shinohara More articles by this author Shin Suzuki More articles by this author Takashige Abe More articles by this author Ataru Sazawa More articles by this author Toru Harabayashi More articles by this author Katsuya Nonomura More articles by this author Expand All Advertisement Loading ...